Anti-MDA5 antibody as a monitoring marker of disease recurrence after lung transplantation in rapidly progressive interstitial lung disease patients.

被引:0
|
作者
Kang, Eun-Suk [1 ,2 ]
Lee, Jong Kwon [1 ]
Heo, Won Young [1 ]
Jung, Mi Jeong [2 ]
Lee, Junghee [3 ]
Jeon, Yeong Jeong [3 ]
Choi, Yong Soo [3 ]
Jeon, Kyeongman [4 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Lab Med & Genet, Seoul, South Korea
[2] Samsung Med Ctr, Res Inst Future Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea
关键词
D O I
10.1097/01.tp.0001065004.59162.12
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
263.3
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Anti-MDA5 antibody as a monitoring marker of disease recurrence after lung transplantation in rapidly progressive interstitial lung disease patients.
    Kang, Eun-Suk
    Lee, Jong Kwon
    Heo, Won Young
    Jung, Mi Jeong
    Lee, Junghee
    Jeon, Yeong Jeong
    Choi, Yong Soo
    Jeon, Kyeongman
    TRANSPLANTATION, 2024, 108 (09) : 138 - 138
  • [2] A Case of Anti-MDA5 Antibody Polymyositis with Rapidly Progressive Interstitial Lung Disease
    MacDonald, D.
    Syed, M. K. Hayat
    Ingbar, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE DUE TO ANTI-MDA5 ANTIBODY WITHOUT DERMATOMYOSITIS
    Qadri, Anum N.
    Jimenez, Javier Blanco
    CHEST, 2024, 166 (04) : 3367A - 3368A
  • [4] Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
    A. Selva-O’Callaghan
    F. Romero-Bueno
    E. Trallero-Araguás
    A. Gil-Vila
    J. C. Ruiz-Rodríguez
    O. Sánchez-Pernaute
    I. Pinal-Fernández
    Current Treatment Options in Rheumatology, 2021, 7 : 319 - 333
  • [5] Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
    Selva-O'Callaghan, A.
    Romero-Bueno, F.
    Trallero-Araguas, E.
    Gil-Vila, A.
    Ruiz-Rodriguez, J. C.
    Sanchez-Pernaute, O.
    Pinal-Fernandez, I.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (04) : 319 - 333
  • [6] Rapidly Progressive Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
    Thomas, M.
    Deshpande, P.
    Tran, L.
    Sampath, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [8] Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease
    Bay, Pierre
    de Chambrun, Marc Pineton
    Rothstein, Vincent
    Mahevas, Matthieu
    De Prost, Nicolas
    Roux, Antoine
    Zuber, Benjamin
    Biet, Dominique Israel
    Hervier, Baptiste
    Tazi, Abdellatif
    Mouthon, Luc
    Mekinian, Arsene
    Deligny, Christophe
    Borie, Raphael
    Meurice, Jean Claude
    Meyer, Alain
    Priou, Pascaline
    Savale, Laurent
    Martin, Luc De Saint
    Gallay, Laure
    Cottin, Vincent
    Blanchard, Elodie
    Brillet, Pierre-Yves
    Khafagy, Philippe
    Benveniste, Olivier
    Nunes, Hilario
    Allenbach
    Uzunhan, Yurdaguel
    JOURNAL OF AUTOIMMUNITY, 2022, 133
  • [9] Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
    Tavakolian, Kameron
    Odak, Mihir
    Mararenko, Anton
    Ilagan, Justin
    Douedi, Steven
    Khan, Taimoor
    Al Saoudi, Ghadier
    JOURNAL OF MEDICAL CASES, 2022, 13 (08) : 374 - 379
  • [10] LATE DIAGNOSIS OF ANTI-MDA5 ANTIBODY-POSITIVE RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE WITH CUTANEOUS MANIFESTATIONS
    Kay, Carl
    Anderson, Erika
    Askin, Cyrus
    Warren, Whittney
    CHEST, 2020, 158 (04) : 1624A - 1624A